Aciphex

MARCH 01, 2004

Eisai Inc (Teaneck, NJ) recently announced that it has assumed US distribution responsibilities for Aciphex (rabeprazole sodium) from Janssen Pharmaceutica Inc affiliate JOM Pharmaceutical Services. Eisai and Janssen will continue to co-promote Aciphex, a proton pump inhibitor prescribed for gastro-esophageal reflux disease (GERD). Eisai is fulfilling purchase orders for Aciphex from a contract distribution center in Memphis, Tenn.The product is indicated for the treatment of symptomatic GERD, healing of erosive GERD, and maintenance of healed erosive GERD. Aciphex also is approved as part of the first 7-day treatment for Helicobacter pylori infections, the single most common cause of peptic ulcers. For more information, visit www.aciphex.com, or call 888-4ACIPHEX (888-422-4743).



SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.